FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

AAGILENT TECHNOLOGIES, INC.

Inspect →

AAAlcoa Corp

Inspect →

AAAUGoldman Sachs Physical Gold ETF

Inspect →

AACAres Acquisition Corp III

Inspect →

AACGATA Creativity Global

Inspect →

AACIArmada Acquisition Corp. III

Inspect →

AACOAbony Acquisition Corp. I

Inspect →

AACPApogee Acquisition Corp

Inspect →

AADXApplied Aerospace & Defense, Inc.

Inspect →

AAGHAmerica Great Health

Inspect →

AALAmerican Airlines Group Inc.

Inspect →

AAMEATLANTIC AMERICAN CORP

Inspect →

03 / FINANCIAL CHANGES

Telomir Pharmaceuticals, Inc. TELO

Pharmaceutical Preparations · SIC 2834

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-06 · Retrieved: 2026-11-10

Compared with the same period of the prior year, ending 2025-09-30.

Revenue—

USD million

No comparable prior-year value

Net income-0.71

USD million

Change year over year: +0.40

Operating cash flow-0.59

USD million

Change year over year: +0.34

Total liabilities0.24

USD million

Change year over year: -0.19

Total assets4.64

USD million

Change year over year: -2.76

Liabilities / assets: 5.1% · Change: -0.6 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-03-17 · Retrieved: 2026-11-10

Compared with the same period of the prior year, ending 2024-12-31.

Revenue—

USD million

No comparable prior-year value

Net income-10.41

USD million

Change year over year: +6.12

Operating cash flow-3.69

USD million

Change year over year: +1.38

Total liabilities1.43

USD million

Change year over year: +0.75

Total assets7.34

USD million

Change year over year: +6.02

Liabilities / assets: 19.5% · Change: -32.0 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
MDCX ↗	2025-12-31	—	—	—
SEPN ↗	2025-12-31	45.95	-106.4%	239.8%
ZYME ↗	2025-12-31	105.97	-76.6%	-31.1%
AVBP ↗	2025-12-31	—	—	—
XERS ↗	2025-12-31	291.85	0.2%	9.8%
RANI ↗	2025-12-31	1.63	-1,817.1%	-1,146.0%

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

WBTN ↗

WEBTOON Entertainment Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

SEPN ↗

Septerna, Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

ISPR ↗

Ispire Technology Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

BAM ↗

Brookfield Asset Management Ltd.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

ZYME ↗

Zymeworks Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

NRXS ↗

Neuraxis, INC

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

GMRS ↗

GMR Solutions Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

STI ↗

Solidion Technology Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

DOUG ↗

Douglas Elliman Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

AVBP ↗

ArriVent BioPharma, Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

LINE ↗

Lineage, Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

GLXY ↗

Galaxy Digital Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →